Quoin Pharmaceuticals, Ltd.
QNRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $4 | $7 | $7 |
| - Cash | $4 | $2 | $3 | $7 |
| + Debt | $3 | $4 | $4 | $744 |
| Enterprise Value | -$1 | $6 | $8 | $744 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$9 | -$9 | -$9 | -$20 |
| % Margin | – | – | – | – |
| Net Income | -$9 | -$9 | -$9 | -$21 |
| % Margin | – | – | – | – |
| EPS Diluted | -66.85 | -337.47 | -22.97 | -28,543.2 |
| % Growth | 80.2% | -1,369.2% | 99.9% | – |
| Operating Cash Flow | -$8 | -$8 | -$8 | -$6 |
| Capital Expenditures | $0 | $0 | -$0 | -$1 |
| Free Cash Flow | -$8 | -$8 | -$9 | -$6 |